Ranolazine
- Product NDC
- 90096-151
- 11-digit product format
- 900960151
- Labeler code
- 90096
- Product ID
- 90096-151_e64620da-e2d0-47d8-a75e-22a8b4db1183
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- ranolazine
- Dosage form
- TABLET, FILM COATED, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Zameer Pharmaceuticals LLC
- Application
- ANDA213085
- Marketing category
- ANDA
- Marketing start
- 2026-04-22
- Substance
- RANOLAZINE
- Active strength
- 500 mg/1
- Pharmacologic classes
- Anti-anginal [EPC], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 90096-151-60 | Ranolazine | 60 in 1 BOTTLE | TABLET, FILM COATED, EXTENDED RE | 60 | | 4 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 90096-151-60 | 90096015160 | 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (90096-151-60) | 2026-04-22 | No | No | Historical |